{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "7733298", "DateCompleted": {"Year": "1995", "Month": "06", "Day": "01"}, "DateRevised": {"Year": "2017", "Month": "12", "Day": "13"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0002-9513", "JournalIssue": {"Volume": "268", "Issue": "4 Pt 1", "PubDate": {"Year": "1995", "Month": "Apr"}}, "Title": "The American journal of physiology", "ISOAbbreviation": "Am J Physiol"}, "ArticleTitle": "Modulation of Ca2+ influx by a mediator released from human tracheal epithelial cells exposed to ozone in vitro.", "Pagination": {"StartPage": "L558", "EndPage": "L564", "MedlinePgn": "L558-64"}, "Abstract": {"AbstractText": ["Intracellular free Ca2+ ([Ca2+]i) plays a vital role both in maintaining normal cellular function and in cell killing. Few studies have been published regarding its role in ozone (O3)-induced health effects. This study investigated the effect and mechanism of O3 exposure on [Ca2+]i in human tracheal epithelial (HTE) cells. HTE cells grown on Costar Transwell inserts with a liquid-gas interface were exposed to 0, 0.05, 0.1, 0.2 and 0.4 ppm O3 at 37 degrees C for 1 h. After exposure, [Ca2+]i was measured using the fluorescent dye Fluo 3. O3 at 0.4 ppm produced a significant increase in [Ca2+]i, and the increases in [Ca2+]i were blocked by verapamil and 8-(diethylamino)-octyl-3,4,5,-trimethoxybenzoate (TMB-8). These results suggest that the O3-induced [Ca2+]i elevation may involve both Ca2+ release from internal stores and Ca2+ influx across the plasma membrane. Furthermore, both buffer and cell lysate of HTE cells exposed to 0.4 ppm O3 caused a rapid increase in [Ca2+]i of THP-1 human phagocytic monocytes, but the buffer and lysate from air exposed cells did not. These results suggest that O3 exposure causes HTE cells to release a diffusible mediator from the empty Ca(2+)-storing organelle and may be responsible for the sustained and persistent [Ca2+]i elevation in HTE cells exposed to 0.4 ppm O3."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Environmental Medicine, New York University Medical Center, Tuxedo 10987, USA."}], "Identifier": [], "LastName": "Qu", "ForeName": "Q S", "Initials": "QS"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Chen", "ForeName": "L C", "Initials": "LC"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, Non-P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Am J Physiol", "NlmUniqueID": "0370511", "ISSNLinking": "0002-9513"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Calcium Channel Blockers"}, {"RegistryNumber": "0", "NameOfSubstance": "Inflammation Mediators"}, {"RegistryNumber": "57818-92-5", "NameOfSubstance": "8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate"}, {"RegistryNumber": "632XD903SP", "NameOfSubstance": "Gallic Acid"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "CJ0O37KU29", "NameOfSubstance": "Verapamil"}, {"RegistryNumber": "SY7Q814VUP", "NameOfSubstance": "Calcium"}], "MeshHeadingList": [{"QualifierName": ["metabolism"], "DescriptorName": "Calcium"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Calcium Channel Blockers"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Epithelial Cells"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Epithelium"}, {"QualifierName": ["analogs & derivatives", "pharmacology"], "DescriptorName": "Gallic Acid"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Inflammation Mediators"}, {"QualifierName": ["metabolism"], "DescriptorName": "Intracellular Membranes"}, {"QualifierName": ["metabolism"], "DescriptorName": "Monocytes"}, {"QualifierName": [], "DescriptorName": "Osmolar Concentration"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ozone"}, {"QualifierName": ["metabolism"], "DescriptorName": "Phagocytes"}, {"QualifierName": ["cytology", "drug effects", "metabolism"], "DescriptorName": "Trachea"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Verapamil"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1995", "Month": "4", "Day": "1"}, {"Year": "1995", "Month": "4", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1995", "Month": "4", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["7733298", "10.1152/ajplung.1995.268.4.L558"]}}], "PubmedBookArticle": []}